Treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
1 month ago
[{"url":"https://i.ytimg.com/vi/KVqkRMervQs/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLDhU8kHrnC1nqhPKZ0zVbZ5x6kUgA","width":360,"height":202},{"url":"https://i.ytimg.com/vi/KVqkRMervQs/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLCuT02c2Z4vpZc7bUo_yTCXUDUElQ","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/KVqkRMervQs/mqdefault_6s.webp?du=3000&sqp=CPvGsKkG&rs=AOn4CLBxVeWfCyFOG_76xKk-5edqRKyuIQ","width":320,"height":180}
[{"text":"In this "},{"text":"video","bold":true},{"text":", Marc Braunstein, MD, PhD, NYU Long Island School of Medicine, New York City, NY, shares some insights into\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma by VJHemOnc \u2013 Video Journal of Hematological Oncology 67 views 1 month ago 1 minute, 56 seconds","duration":"1 minute, 56 seconds"}